Stage III Nasopharyngeal Carcinoma AJCC v7
specificStage III includes: (T1, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T2: Nasopharyngeal cancer with parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T3: Nasopharyngeal cancer with tumor involving bony str
9
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Stage III Nasopharyngeal Carcinoma AJCC v7(9)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive | 55.6 |
| 2 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 55.6 |
| 3 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | 55.6 |
| 4 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 55.6 |
| 5 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 55.6 |
| 6 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive | 55.6 |
| 7 | University of Illinois Cancer CenterChicago, IL | 55.6 |
| 8 | Cancer Center at IllinoisUrbana, IL | 55.6 |
| 9 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 55.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →